ADP-0000-002: Long Term Follow-up of Subjects Exposed to NY-ESO-1c259 T A Genetically Engineered NY-ESO-1 Specific T Cell Receptor
Enrolling By Invitation
99 years or below
All
Phase
N/A
1 Location
Brief description of study
This non-therapeutic, multi-center LTFU study involves up to 15 years post-infusion monitoring of subjects who have been exposed to lentivirus-mediated gene transfer in Adaptimmune clinical studies. Subjects will undergo clinical evaluation with careful attention to adverse events possibly related to gene transfer/lentivirus-induced diseases. Blood samples will be collected. Subjects will be followed for survival.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: TBD,tbd,tbd
-
Age: 99 years or below
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 828774
If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu
